Food restriction and refeeding induces changes in lipid pathways and fat deposition in the adipose and hepatic tissues in rats with diet-induced obesity

Experimental Physiology

Volumn 97, Issue 7, 2012, Pages 882-894

  Duarte, Fernanda Oliveira ^a   Sene Fiorese, Marcela ^a   Cheik, Nadia Carla ^b   Maria, Adriana Simone Lopes Santa ^a   de Aquino Jr , Antônio Eduardo ^a   Oishi, Jorge Camargo ^a   Rossi, Elizeu Antônio ^c   Garcia de Oliveira Duarte, Ana Cláudia ^a   Dâmaso, Ana Raimunda ^d  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^c State University Julio de Mesquita Filho   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FAT; LEPTIN; LIPID; TRIOLEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CALORIC RESTRICTION; CONTROLLED STUDY; DECAPITATION; DIET RESTRICTION; DYSLIPIDEMIA; IN VIVO STUDY; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; LIVER; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT; REFEEDING; RISK; WHITE ADIPOSE TISSUE;

EID: 84863849213     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.064121     Document Type: Article

References (59)

1. Angulo P (2007). Obesity and nonalcoholic fatty liver disease. Nutr Rev 65, S57-S63.
2. Archer ZA & Mercer JG (2007). Brain responses to obesogenic diets and diet-induced obesity. Proc Nutr Soc 66, 124-130.
3. Beck B (2006). Neuropeptide Y in normal eating and in genetic and dietary-induced obesity. Philos Trans R Soc Lond B Biol Sci 361, 1159-1185.
4. Caranti DA, de Mello MT, Prado WL, Tock L, Siqueira KO, de Piano A, Lofrano MC, Cristofalo DM, Lederman H, Tufik S & Dâmaso AR (2007). Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents. Metabolism 56, 1293-1300.
5. Carnier J, de Piano A, de Lima Sanches P, Tock L, do Nascimento CM, Oyama LM, Corrêa FA, Ernandes RH, Lederman H, de Mello MT, Tufik S & Dâmaso AR (2010). The role of orexigenic and anorexigenic factors in an interdisciplinary weight loss therapy for obese adolescents with symptoms of eating disorders. Int J Clin Pract 64, 784-790.
6. Cinti S (2005). The adipose organ. Prostaglandins Leukot Essent Fatty Acids 73, 9-15.
7. Cohen P & Friedman JM (2004). Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr 134, 2455S-2463S.
8. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP & Purnell JQ (2002). Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346, 1623-1630.
9. Dâmaso AR, de Piano A, Sanches PL, Corgosinho F, Tock L, Oyama LM, do Nascimento CM, Tufik S & de Mello MT (2011). Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss. Peptides 32, 1384-1391.
10. Dâmaso AR, Tock L, Prado W, Piano A, Caranti DA, Tufik S & Mello MT. (2006). Multidisciplinary therapy reduces visceral adipose tissue, leptin, ghrelin and prevalence of the non-alcoholic fatty liver disease (NAFLD) in obese adolescents. [Article in Portuguese.] Braz J Sports Medicine 12, 1-6.
11. Das M, Gabriely I & Barzilai N (2004). Caloric restriction, body fat and ageing in experimental models. Obes Rev 5, 13-19.
12. de Mello MT, de Piano A, Carnier J, Sanches PdeL, Corrêa FA, Tock L, Ernandes RM, Tufik S & Dâmaso AR (2011). Long-term effects of aerobic plus resistance training on the metabolic syndrome and adiponectinemia in obese adolescents. J Clin Hypertens (Greenwich) 13, 343-350.
13. de Piano A, Tock L, Carnier J, Foschini D, Sanches PdeL, Corrêa FA, Oyama LM, do Nascimento CM, Lederman HM, Ernandes R, de Mello MT, Tufik S & Dâmaso A (2010a). The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol 22, 557-563.
14. de Piano A, Tock L, Carnier J, Oyama LM, Oller do Nascimento CM, Martinz AC, Foschini D, Sanches PL, Ernandes RM, de Mello MT, Tufik S & Dâmaso AR (2010b). Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. Metabolism 59, 613-619.
15. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJ & Velloso LA (2005). Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199.
16. Duarte ACGO, Fonseca DF, Manzoni MSJ, Soave FC, Sene-Fiorese M & Dâmaso AR (2006). High fat diet and secretory capacity of insulin in rat. [Article in Portuguese.] Rev Nutr 19, 341-348.
17. Duarte FO, Sene-Fiorese M, Manzoni MS, de Freitas LF, Cheik NC, Garcia de Oliveira Duarte AC, Nonaka KO & Dâmaso A (2008). Caloric restriction and refeeding promoted different metabolic effects in fat depots and impaired dyslipidemic profile in rats. Nutrition 24, 177-186.
18. Einstein FH, Atzmon G, Yang XM, Ma XH, Rincon M, Rudin E, Muzumdar R & Barzilai N (2005). Differential responses of visceral and subcutaneous fat depots to nutrients. Diabetes 54, 672-678.
19. El-Haschimi K, Pierroz DD, Hileman SM, Bjørbaek C & Flier JS (2000). Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105, 1827-1832.
20. English PJ, Ghatei MA, Malik IA, Bloom SR & Wilding JPH (2002). Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87, 2984-2987.
21. Estadella D, Oyama LM, Dâmaso AR, Ribeiro EB & Oller Do Nascimento CM (2004). Effect of palatable hyperlipidic diet on lipid metabolism of sedentary and exercised rats. Nutrition 20, 218-224.
22. Ezquer M, Ezquer F, Ricca M, Allers C & Conget P (2011). Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome. J Hepatol 55, 1112-1120.
23. Fishman S, Muzumdar RH, Atzmon G, Ma X, Yang X, Einstein FH & Barzilai N (2007). Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J 21, 53-60.
24. Flier JS. (2004). Obesity wars: molecular progress confronts an expanding epidemic. Cell. 116, 337-530.
25. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI & Lima FB (2007). Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J) 83, S192-S203.
26. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB, Goodpaster B, Visser M & Harris TB (2005). Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 81, 903-910.
27. Gauthier MS, Favier R & Lavoie JM (2006). Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats. Br J Nutr 95, 273-281.
28. Guerra RL, Prado WL, Cheik NC, Viana FP, Botero JP, Vendramini RC, Carlos IZ, Rossi EA & Dâmaso AR (2007). Effects of 2 or 5 consecutive exercise days on adipocyte area and lipid parameters in Wistar rats. Lipids Health Dis 6, 16.
29. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS & Jørgensen JO (2002). Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 56, 203-206.
30. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ & Martin RJ (2001). The biology of white adipocyte proliferation. Obes Rev 2, 239-254.
31. Hermsdorff HHM, Vieira MAQM & Monteiro JBR (2006). Leptin and its influence in the pathophysiology of eating disorders. Rev Nutr 19, 369-379.
32. Kretschmer BD, Schelling P, Beier N, Liebscher C, Treutel S, Krüger N, Scholz HP, Haus A. (2005). Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance. Life Sciences 76, 1553-73.
33. Levin BE & Dunn-Meynell AA (2002). Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 283, R941-R948.
34. Li Y, Bujo H, Takahashi K, Shibasaki M, Zhu Y, Yoshida Y, Otsuka Y, Hashimoto N & Saito Y (2003). Visceral fat: higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat. Exp Biol Med (Maywood) 228, 1118-1123.
35. Lin L, Martin R, Schaffhauser AO & York DA (2001). Acute changes in the response to peripheral leptin with alteration in the diet composition. Am J Physiol Regul Integr Comp Physiol 280, R504-R509.
36. Mars M, de Graaf C, de Groot CP, van Rossum CT & Kok FJ (2006). Fasting leptin and appetite responses induced by a 4-day 65%-energy-restricted diet. Int J Obes (Lond) 30, 122-128.
37. Medina J, Fernández-Salazar LI, García-Buey L & Moreno-Otero R (2004). Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27, 2057-2066.
38. Moraes JC, Coope A, Morari J, Cintra DE, Roman EA, Pauli JR, Romanatto T, Carvalheira JB, Oliveira AL, Saad MJ, Velloso LA. (2009). High-fat diet induces apoptosis of hypothalamic neurons. PLoS One, 4, e5045.
39. Münzberg H, Flier JS & Bjørbaek C (2004). Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145, 4880-4889.
40. Murphy KG & Bloom SR (2004). Gut hormones in the control of appetite. Exp Physiol 89, 507-516.
41. Ogawa R, Strader AD, Clegg DJ, Sakai RR, Seeley RJ & Woods SC (2005). Chronic food restriction and reduced dietary fat: risk factors for bouts of overeating. Physiol Behav 86, 578-585.
42. 14C]triolein. Biochem J 239, 233-236.
43. Oyama LM, do Nascimento CM, Carnier J, de Piano A, Tock L, Sanches PdeL, Gomes FA, Tufik S, de Mello MT & Dâmaso AR (2010). The role of anorexigenic and orexigenic neuropeptides and peripheral signals on quartiles of weight loss in obese adolescents. Neuropeptides 44, 467-474.
44. Pardo M, Roca-Rivada A, Al-Massadi O, Seoane LM, Camina JP & Casanueva FF (2010). Peripheral leptin and ghrelin receptors are regulated in a tissue-specific manner in activity-based anorexia. Peptides 31, 1912-1919.
45. Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J & Grant AM (2004). Effects of weight loss in overweight/obese individuals and long-term lipid outcomes - a systematic review. Obes Rev 5, 43-50.
46. Qureshi K & Abrams GA (2007). Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 13, 3540-3553.
47. Riccardi G, Giacco R & Rivellese AA (2004). Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23, 447-456.
48. Robinson AM & Williamson DH. (1978). Control of glucose metabolism in isolated acine of the lactating mammary gland of the rat: effects of oleat on glucose utilization and lipogenesis. Biochemical Journal 170, 609-613.
49. Sahu A (2003). Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol 24, 225-253.
50. Sea MM, Fong WP, Huang Y & Chen ZY (2000). Weight cycling-induced alteration in fatty acid metabolism. Am J Physiol Regul Integr Comp Physiol 279, R1145-R1155.
51. Sene-Fiorese M, Duarte FO, Scarmagnani FR, Cheik NC, Manzoni MS, Nonaka KO, Rossi EA, de Oliveira Duarte AC & Dâmaso AR (2008). Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet. Obesity (Silver Spring) 16, 2217-2222.
52. Stanley S, Wynne K, McGowan B & Bloom S (2005). Hormonal regulation of food intake. Physiol Rev 85, 1131-1158.
53. Stansbie D, Brownsey RW, Crettaz M, Denton RM. (1976). Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochemical Journal 160, 413-416.
54. Tock L, Prado WL, Caranti DA, Cristofalo DM, Lederman H, Fisberg M, Siqueira KO, Stella SG, Antunes HK, Cintra IP, Tufik S, de Mello MT & Dâmaso AR (2006). Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy. Eur J Gastroenterol Hepatol 18, 1241-1245.
55. Trayhurn P & Bing C (2006). Appetite and energy balance signals from adipocytes. Philos Trans R Soc Lond B Biol Sci 361, 1237-1249.
56. Velloso LA (2006). The hypothalamic control of feeding and thermogenesis: implications on the development of obesity. [Article in Portuguese.] Arq Bras Endocrinol Metabol 50, 165-176.
57. Vernon G, Baranova A & Younossi ZM (2011). Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34, 274-285.
58. Westerterp KR (2006). Perception, passive overfeeding and energy metabolism. Physiol Behav 89, 62-65.
59. Westerterp-Plantenga MS, Saris WH, Hukshorn CJ & Campfield LA (2001). Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 74, 426-434.